Skip to main content
Alhemo 100 mg/mL injection, solution by Novo Nordisk
Alhemo, 100 mg/mL, injection, solution Drug class: Tissue Factor Pathway Inhibitor Antagonist. Available on prescription only. Listed by Novo Nordisk.
Prescription only

Alhemo

concizumab

Listed by Novo Nordisk

Strength
100 mg/mL
Form
Injection, Solution
Route
Subcutaneous
Class
Tissue Factor Pathway Inhibitor Antagonist

What it contains

  • Concizumab 100 mg/mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Drug class Tissue Factor Pathway Inhibitor Antagonist
Approval route BLA — biologic licence
NDC code 0169-2081
FDA application BLA761315
RxNorm concept 2708346
Package sizes listed 1
Marketed since February 2025

Other products containing Concizumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Alhemo

concizumab

Strength
100 mg/mL
Form
Injection, Solution
Class
Tissue Factor Pathway Inhibitor Antagon…
Rx only

Novo Nordisk

Not stocked by us — reference only

Alhemo

concizumab

Strength
40 mg/mL
Form
Injection, Solution
Class
Tissue Factor Pathway Inhibitor Antagon…
Rx only

Novo Nordisk

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.